Pharmaceutical Dissolution Testing Products and Services

Dissolution testing allows for the examination and prediction of the in-vitro behavior of pharmaceutical formulations. Drug release behavior of pre-formulations is made possible by the use of specialized dissolution equipment. By dissolution testing, a researcher can simulate the behavior of capsule, bead, and enteric-coated tablets in-vitro.

Important Applications of Dissolution Testing

  • Quality Control
  • Replicating certain mechanisms of in-vitro drug release
  • Determining if drug behavior meets regulatory standards
  • Dissolution simulation when choosing pharmaceutical excipients

Examples of Pharmaceutical Dissolution Equipment

Paddle apparatus dissolution testing is used to simulate tablet behavior in the gastrointestinal tract. The release behavior of implants and transdermal medications can also be tested with dissolution equipment. The reciprocating cylinder dissolution apparatus ("Bio-Dis") is excellent for examining the dissolution behavior of extended release products. Dissolution analysis is key in determining the homogeneity of the final pharmaceutical product. Whether controlled by the bench user or fully automated, the implementation of a dissolution testing protocol is crucial in the final stages of drug development to ensure the efficacy, safety, and marketability of the final compound.
  • Lifecore Adds Seventh Late-Stage Commercial Manufacturing Program

    Thursday, September 03, 2026
    Lifecore Biomedical has signed an agreement with an undisclosed global pharmaceutical company to transfer manufacturing of a currently marketed injectable drug product, adding what the company expects could become one of its largest commercial contracts. read more
  • Fortrea Agrees to $45M Purchase of Worldwide Early-Phase Unit

    Thursday, September 03, 2026
    Fortrea Holdings has agreed to acquire the Early Phase Services division of Worldwide Clinical Trials in an all-cash transaction valued at about $45 million, adding a Texas clinical pharmacology unit, bioanalytical laboratory and biospecimen storage operation to its early-development network. read more
  • Northway Biotech Opens $72 Million Cell-Therapy CDMO in Vilnius

    Thursday, September 03, 2026
    Northway Biotech has opened a $72 million cell-therapy and personalized-medicine contract development and manufacturing facility in Vilnius, Lithuania, expanding its capacity to develop and produce advanced therapies. read more
  • ARPA-H Awards Up to $125M for Distributed RNA Medicine Manufacturing

    Thursday, September 03, 2026
    The Advanced Research Projects Agency for Health has selected five teams for a program intended to develop automated, distributed manufacturing systems for individualized RNA-based genetic medicines, with up to $125 million available for research and development. read more
  • CPHI Milan Pharma Awards 2026 Finalists Announced

    Tuesday, September 01, 2026
    Informa Markets has announced the finalists for the CPHI Pharma Awards 2026, recognizing outstanding achievements across companies and individuals pushing the boundaries of science and technology to advance global healthcare. read more
We're sorry, no matching articles were found. Please select different filter options and try your search again.
We're sorry, no matching articles were found. Please select different filter options and try your search again.